Director, Endocrinology Fellowship Training and Endocrinology Education, Boston University Medical Center
Endocrinology
Dr. Joshua D. Safer, MD
|
|
Give Review
Joshua D. Safer, MD works in the field of Endocrinology. He graduated from University of Wisconsin School of Medicine and Public Health. He received awards:"Regional Top Doctor". Dr. Joshua D. Safer is a published doctor. He has 31 publications published. The most current publication "Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone." He is registered with Medicare and accepts Medicare payments.
Publications
- Topical Thyroid hormone accelerates wound healing in mice.
- Role for inner ring deiodination preventing transcutaneous passage of thyroxine.
- The Thyroid Hormone Degrading Type 3 Deiodinase Is the Primary Deiodinase Active in Murine Epidermis.
- Thyroid hormone action on skin.
- Thyroid hormone and wound healing.
- Transgender Medical Research, Provider Education, and Patient Access are Overdue.
- Out of the shadows: it is time to mainstream treatment for transgender patients.
- Topical triiodothyronine stimulates epidermal proliferation, dermal thickening, and hair growth in mice and rats.
- A simple curriculum content change increased medical student comfort With transgender medicine.
- Thyroid hormone action on skin: diverging effects of topical versus intraperitoneal administration.
- A role for Thyroid hormone in wound healing through keratin gene expression.
- In Thyroid fine-needle aspiration, use of bedside-prepared slides significantly increased diagnostic adequacy and specimen cellularity relative to solution-based samples.
- Finding the Right Balance Between Resistance & Sensitivity: A Review of the Cardiac Manifestations of the Syndrome of Resistance to Thyroid Hormone and the Implication...
- Graves Disease and Gynecomastia in Two Roomates.
- Male sex, African American race or ethnicity, and triiodothyronine levels at diagnosis predict weight gain after antiThyroid medication and radioiodine therapy for hyp...
- A Thyroid hormone deiodinase inhibitor can decrease cutaneous cell proliferation in vitro.
- Diagnostic confusion attributable to spurious elevation of both total Thyroid hormone and Thyroid hormone uptake measurements in the setting of autoantibodies: case re...
- A topical paraThyroid hormone/paraThyroid hormone-related peptide receptor antagonist stimulates hair growth in mice.
- AMPK regulation of the growth of cultured human keratinocytes.
- There is reason for optimism: an introduction to the special issue on research needs in transgender health and medicine.
- Barriers to healthcare for transgender individuals.
- Adrenal metastasis secondary to papillary Thyroid carcinoma.
- Twenty-one-gauge needles provide more cellular samples than twenty-five-gauge needles in fine-needle aspiration biopsy of the Thyroid but may not provide increased dia...
- A pituitary tumor in a patient with Thyroid hormone resistance: a diagnostic dilemma.
- Progress on the road to better medical care for transgender patients.
- Defective release of corepressor by hinge mutants of the Thyroid hormone receptor found in patients with resistance to Thyroid hormone.
- A unique role of the beta-2 Thyroid hormone receptor isoform in negative regulation by Thyroid hormone. Mapping of a novel amino-terminal domain important for ligand-i...
- The Thyroid hormone receptor-beta gene mutation R383H is associated with isolated central resistance to Thyroid hormone.
- Isoform variable action among Thyroid hormone receptor mutants provides insight into pituitary resistance to Thyroid hormone.
- Advancing methods for US transgender health research.
Schools
University of Wisconsin Madison
Beth Israel Med Center
Beth Israel Hospital Harvard Med School
Conditions Treated
- Abnormal Thyroid
- Adrenal Incidentaloma
- Calcium Metabolism Disorders
- Diabetes Type 1
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Beth Israel Deaconess Medical Center -
Mount Sinai Beth Israel -
University of Wisconsin School of Medicine and Public Health
Hospital
-
Boston Medical Center
Drug Facts
| NPI NUMBER | 1225018245 | |
| NPPES Provider LastName | SAFER | |
| NPPES Provider FirstName | JOSHUA | |
| NPPES Provider ZIPCode | 021182309 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 503.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225018245 |
| Last Name Of The Provider | SAFER |
| First Name Of The Provider | JOSHUA |
| View All |
Similar Doctors
|
|
Dr. Klara J. Rosenquist, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamara L. Wexler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Qin Yang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon J. Strewler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Yialamas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven E. Shoelson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|